A Comprehensive Guide to Paget’s Disease of Bone

Sanjay Kumar Chintakayala; Aalekhya Ravipati; Vinod Kumar Mugada; Srinivasa Rao Yarguntla

doi:10.52711/2321-5836.2023.00033

Research Journal of Pharmacology and Pharmacodynamics

ISSN

2321-5836 (Online)
0975-4407 (Print)

Submit Article

A Comprehensive Guide to Paget’s Disease of Bone

Author(s): Sanjay Kumar Chintakayala, Aalekhya Ravipati, Vinod Kumar Mugada, Srinivasa Rao Yarguntla

Email(s): sanjaykumarchintakayala@gmail.com

DOI: 10.52711/2321-5836.2023.00033

Address: Sanjay Kumar Chintakayala1*, Aalekhya Ravipati1, Vinod Kumar Mugada1, Srinivasa Rao Yarguntla2
1Department of Pharmacy Practice, Vignan Institute of Pharmaceutical Technology, Duvvada, AP, India.
2Department of Pharmaceutics, Vignan Institute of Pharmaceutical Technology, Duvvada, AP, India.
*Corresponding Author

Published In: Volume - 15, Issue - 4, Year - 2023

View HTML

View PDF

ABSTRACT:
PDB is a long-standing pathological stateillustrated by aberrant bone remodeling and metabolism arising in structural anomalies of the bone tissue. While this disease may remain asymptomatic, mild symptoms such as joint and bone discomfort may be present. However, an early warning sign is intense nocturnal bone pain. Moreover, PDB may result in complications such as deafness, fractures, compression of cranial nerves or the spinal cord, and hydrocephalus. This disease is more frequently observed in individuals above the age of 50, affecting individuals of all races and ethnicities, with a slightly higher prevalence in males. Diagnosis of PDB involves comprehensive clinical assessment, patient history, and specialized tests. Pharmacological treatments such as bisphosphonates, calcitonin, and surgical intervention may be employed to manage the disease. Supplementation is essential to prevent hypocalcemia. PDB may lead to rare complications, including sarcomatous conversion of the pagetic lesion and high-output congestive heart failure which concerns healthcare professionals.

Keywords:

Cite this article:
Sanjay Kumar Chintakayala, Aalekhya Ravipati, Vinod Kumar Mugada, Srinivasa Rao Yarguntla. A Comprehensive Guide to Paget’s Disease of Bone. Research Journal of Pharmacology and Pharmacodynamics.2023;15(4):186-0. doi: 10.52711/2321-5836.2023.00033

Cite(Electronic):
Sanjay Kumar Chintakayala, Aalekhya Ravipati, Vinod Kumar Mugada, Srinivasa Rao Yarguntla. A Comprehensive Guide to Paget’s Disease of Bone. Research Journal of Pharmacology and Pharmacodynamics.2023;15(4):186-0. doi: 10.52711/2321-5836.2023.00033 Available on: https://rjppd.org/AbstractView.aspx?PID=2023-15-4-7

REFERENCES:
1.   Paget, J. On a Form of Chronic Inflammation of Bones (Osteitis Deformans). Journal of the Royal Society of Medicine. 1877;MCT-60(1), 37–63. https://doi.org/10.1177/095952877706000105
2.   Van Staa, T. P., Selby, P., Leufkens, H. G. M., Lyles, K., Sprafka, J. M., and Cooper, C. Incidence and Natural History of Paget’s Disease of Bone in England and Wales. Journal of Bone and Mineral Research. 2002;17(3), 465–471. https://doi.org/10.1359/jbmr.2002.17.3.465
3.   Falch, J. A. PAGET’S DISEASE IN NORWAY. The Lancet. 1979;314(8150), 1022. https://doi.org/10.1016/s0140-6736(79)92601-1
4.   Siris, E. S., Ottman, R., Flaster, E., and Kelsey, J. L. Familial aggregation of Paget's disease of bone. Journal of Bone and Mineral Research. 2009;6(5), 495–500. https://doi.org/10.1002/jbmr.5650060511
5.   Seton, M., Choi, H. K., Hansen, M. F., Sebaldt, R. J., and Cooper, C. Analysis of Environmental Factors in Familial Versus Sporadic Paget’s Disease of Bone-The New England Registry for Paget’s Disease of Bone. Journal of Bone and Mineral Research.2003;18(8), 1519–1524. https://doi.org/10.1359/jbmr.2003.18.8.1519
6.   Alonso, N., Calero-Paniagua, I., and del Pino-Montes, J. Clinical and Genetic Advances in Paget’s Disease of Bone: a Review. Clinical Reviews in Bone and Mineral Metabolism. 2016;15(1), 37–48. https://doi.org/10.1007/s12018-016-9226-0
7.   Lyles, K. W., Siris, E. S., Singer, F. R., and Meunier, P. J. A Clinical Approach to Diagnosis and Management of Paget’s Disease of Bone. Journal of Bone and Mineral   Research. 2001; 16(8), 1379–1387. https://doi.org/10.1359/jbmr.2001.16.8.1379
8.   Ralston, S. H. Paget’s Disease of Bone. New England Journal of Medicine. 2013;368(7), 644–650. https://doi.org/10.1056/nejmcp1204713
9.   KaoutherMaatallah. Paget’s Disease of Bone in Patients under 40 Years. Sultan Qaboos University Medical Journal [SQUMJ]. 2021;21(1), e127-131. https://www.academia.edu/60447145/Paget_s_Disease_of_Bone_in_Patients_under_40_Years
10.   Walsh, J. P. Paget’s disease of bone. Medical Journal of Australia. 2004; 181(5), 262–265. https://doi.org/10.5694/j.1326-5377.2004.tb06265.x
11.   Altman, R. D., and Collins, B. Musculoskeletal manifestations of Paget's disease of bone. Arthritis and Rheumatism. 1980;23(10), 1121–1127. https://doi.org/10.1002/art.1780231008
12.   Wang, Q.-Y., Fu, S.-J., Ding, N., Liu, S.-Y., Chen, R., Wen, Z.-X., Fu, S., Sheng, Z.-F., and Ou, Y.-N. Clinical features, diagnosis, and treatment of Paget's disease of bone in mainland China: A systematic review. Reviews in Endocrine and Metabolic Disorders. 2020; 21(4), 645–655. https://doi.org/10.1007/s11154-020-09544-x
13.   López-Abente, G., Morales-Piga, A., Elena-Ibáñez, A., Rey-Rey, J. S., and Corres-González, J. Cattle, Pets, and Pagetʼs Disease of Bone. Epidemiology 1997; 8(3), 247. https://doi.org/10.1097/00001648-199705000-00004
14.   Gennari, L., Merlotti, D., Martini, G., and Nuti, R. Paget’s Disease of Bone in Italy. Journal of Bone and Mineral Research. 2006; 21(S2), P14–P21. https://doi.org/10.1359/jbmr.06s203
15.   Mills, B. G., and Singer, F. R. Nuclear Inclusions in Paget’s Disease of Bone. Science. 1976; 194(4261), 201–202.
16.   Basle, M. F., Fournier, J. G., Rozenblatt, S., Rebel, A., and Bouteille, M. Measles Virus RNA Detected in Paget’s Disease Bone Tissue by in situ Hybridization. Journal of General Virology. 1986;67(5), 907–913. https://doi.org/10.1099/0022-1317-67-5-907
17.   Reddy, S. V., Singer, F. R., and Roodman, G. D. Bone marrow mononuclear cells from patients with Paget’s disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. The Journal of Clinical Endocrinology and Metabolism. 1995;80(7), 2108–2111. https://doi.org/10.1210/jcem.80.7.7608263
18.   Friedrichs, W. E., Reddy, S. V., Bruder, J. M., Cundy, T., Cornish, J., Singer, F. R., and Roodman, G. D. Sequence Analysis of Measles Virus Nucleocapsid Transcripts in Patients with Paget’s Disease. Journal of Bone and Mineral Research. 2002; 17(1), 145–151. https://doi.org/10.1359/jbmr.2002.17.1.145
19.   Deftos, L. J. Treatment of Paget’s Disease — Taming the Wild Osteoclast. New England Journal of Medicine. 2005; 353(9), 872–875. https://doi.org/10.1056/nejmp058184
20.   Boyle, W. J., Simonet, W. S., and Lacey, D. L. Osteoclast differentiation and activation. Nature. 2003;423(6937), 337–342. https://doi.org/10.1038/nature01658
21.   Laurin N, Brown JP, Morissette J, Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet. 2002 Jun;70(6):1582-8. doi;10.1086/340731.
22.   Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet. 2002 Oct 15;11(22):2735-9. doi: 10.1093/hmg/11.22.2735.
23.   Goode A, Long JE, Shaw B, Ralston SH, Visconti MR, Gianfrancesco F, Esposito T, Gennari L, Merlotti D, Rendina D, Rea SL, Sultana M, Searle MS, Layfield R. Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function. Biochim Biophys Acta. 2014 Jul;1842(7):992-1000. doi: 10.1016/j.bbadis.2014.03.006.
24.   Lucas, G. J., Daroszewska, A., and Ralston, S. H. Contribution of Genetic Factors to the Pathogenesis of Paget’s Disease of Bone and Related Disorders. Journal of Bone and Mineral Research. 2006;21(S2), P31–P37. https://doi.org/10.1359/jbmr.06s206
25.   Yochum TR. Paget’s sarcoma of bone. Der Radiologe. 2021; 24(9). https://pubmed.ncbi.nlm.nih.gov/6593768/
26.   Tan, A., and Ralston, S. H. Clinical Presentation of Paget’s Disease: Evaluation of a Contemporary Cohort and Systematic Review. Calcified Tissue International. 2014; 95(5), 385–392. https://doi.org/10.1007/s00223-014-9904-1
27.   Corral-Gudino, L., Borao-Cengotita-Bengoa, M., Del Pino-Montes, J., and Ralston, S. Epidemiology of Paget’s disease of bone: A systematic review and meta-analysis of secular changes. Bone. 2013;55(2), 347–352. https://doi.org/10.1016/j.bone.2013.04.024
28.   Gumà, M., Rotés, D., Holgado, S., Monfort, J., Olivé, A., Carbonell, J., and Tena, X. Enfermedadósea de Paget: estudio de 314 pacientes. MedicinaClínica. 2002;119(14), 537–540. https://doi.org/10.1016/s0025-7753(02)73487-8.
29.   Al Nofal, A. A., Altayar, O., BenKhadra, K., Qasim Agha, O. Q., Asi, N., Nabhan, M., Prokop, L. J., Tebben, P., and Murad, M. H. Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis. Osteoporosis International. 2015; 26(7), 1875–1891. https://doi.org/10.1007/s00198-015-3095-0
30.   Davis, M. A., Scalcione, L. R., Gimber, L. H., Thompson, R. B., Avery, R. J., and Taljanovic, M. S. Paget Sarcoma of the Pelvic Bone With Widespread Metastatic Disease on Radiography, CT, MRI, and 18F-FDG PET/CT With Pathologic Correlation. Clinical Nuclear Medicine. 2014; 39(4), 371–373. https://doi.org/10.1097/rlu.0000000000000384
31.   Selby, P. L., Davie, M. W. J., Ralston, S. H., and Stone, M. D. Guidelines on the management of Paget’s disease of bone*. Bone. 2002;31(3), 366–373. https://doi.org/10.1016/s8756-3282(02)00817-7
32.   Seitz, S., Priemel, M., Zustin, J., Beil, F. T., Semler, J., Minne, H., Schinke, T., and Amling, M. Paget’s Disease of Bone: Histologic Analysis of 754 Patients. Journal of Bone and Mineral Research. 2009; 24(1), 62–69. https://doi.org/10.1359/jbmr.080907
33.   Kravets, I. Paget’s Disease of Bone: Diagnosis and Treatment. The American Journal of Medicine. 2018;131(11), 1298–1303. https://doi.org/10.1016/j.amjmed.2018.04.028
34.   Appelman-Dijkstra, N. M., and Papapoulos, S. E. Paget’s disease of bone. Best Practice and Research Clinical Endocrinology and Metabolism. 2018; 32(5), 657–668. https://doi.org/10.1016/j.beem.2018.05.005
35.   Adams C; Banks KP. Bone Scan. 2022;https://pubmed.ncbi.nlm.nih.gov/30285381/
36.   Zimmermann, E. A., Köhne, T., Bale, H. A., Panganiban, B., Gludovatz, B., Zustin, J., Hahn, M., Amling, M., Ritchie, R. O., and Busse, B. Modifications to Nano- and Microstructural Quality and the Effects on Mechanical Integrity in Paget’s Disease of Bone. Journal of Bone and Mineral Research. 2015; 30(2), 264–273. https://doi.org/10.1002/jbmr.2340
37.   Guido, G., Scaglione, M., Fabbri, L., and Ceglia, M. J. The "osteoporosis disease". Clinical Cases in Mineral and Bone Metabolism, 2009; 6(   2), 114.
38.   Chen, X., Wang, Z., Duan, N., Zhu, G., Schwarz, E. M., and Xie, C. Osteoblast–osteoclast interactions. Connective Tissue Research, 2018; 59(2), 99-107.https://doi.org/10.1080/03008207.2017.1290085.
39.   Walsh, M. C., and Choi, Y. Biology of the RANKL–RANK–OPG system in immunity, bone, and beyond. Frontiers in Immunology, 2014; 5, 511.https://doi.org/10.3389/fimmu.2014.00511.
40.   Ono, T., Hayashi, M., Sasaki, F., and Nakashima, T. RANKL biology: bone metabolism, the immune system, and beyond. Inflammation and Regeneration, 2020; 40(1), 1-16.https://doi.org/10.1186/s41232-019-0111-3.
41.   Ralston, S. H., Langston, A. L., and Reid, I. R. Pathogenesis and management of Paget’s disease of bone. The Lancet. 2008; 372(9633), 155–163. https://doi.org/10.1016/s0140-6736(08)61035-1
42.   Siris, E. S., Lyles, K. W., Singer, F. R., and Meunier, P. J. Medical Management of Paget’s Disease of Bone: Indications for Treatment and Review of Current Therapies. Journal of Bone and Mineral Research. 2006;21(S2), P94–P98. https://doi.org/10.1359/jbmr.06s218
43.   Singer, F. R. Paget disease: when to treat and when not to treat. Nature Reviews Rheumatology. 2009; 5(9), 483–489. https://doi.org/10.1038/nrrheum.2009.149
44.   Siris, E. S., and Feldman, F. Clinical Vignette: Natural History of Untreated Paget’s Disease of the Tibia. Journal of Bone and Mineral Research. 1997;12(4), 691–692. https://doi.org/10.1359/jbmr.1997.12.4.691
45.   Reid, I. R., Miller, P., Lyles, K., Fraser, W., Brown, J. P., Saidi, Y., Mesenbrink, P., Su, G., Pak, J., Zelenakas, K., Luchi, M., Richardson, P., and Hosking, D. Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget’s Disease. New England Journal of Medicine. 2005; 353(9), 898–908. https://doi.org/10.1056/nejmoa044241
46.   Vasireddy, S., Talwalkar, A., Miller, H., Mehan, R., and Swinson, D. R. Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate. Clinical Rheumatology. 2003; 22(6), 376–380.https://doi.org/10.1007/s10067-003-0762-x
47.   Crandall,c. Risedronate. Archives of Internal Medicine.2001;161(3), 353. https://doi.org/10.1001/archinte.161.3.353
48.   Walsh, J. P., Ward, L. C., Stewart, G. O., Will, R. K., Criddle, R. A., Prince, R. L., Stuckey, B. G. A., Dhaliwal, S. S., Bhagat, C. I., Retallack, R. W., Kent, G. N., Drury, P. J., Vasikaran, S., and Gutteridge, D. H. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget’s disease of bone. Bone. 2004;34(4), 747–754. https://doi.org/10.1016/j.bone.2003.12.011
49.   Morales-Piga, A. Tiludronate. A new treatment for an old ailment: Paget’s disease of bone. Expert Opinion on Pharmacotherapy. 1999; 1(1), 157–170. https://doi.org/10.1517/14656566.1.1.157
50.   Martin, T. J. Treatment of Paget's Disease with the Calcitonins*. Australian and New Zealand Journal of Medicine. 1979;9(1), 36–43. https://doi.org/10.1111/j.1445-5994.1979.tb04110.x
51.   Bone, H. G. Non-malignant Complications of Paget's Disease. Journal of Bone and Mineral Research. 2006; 21(S2), P64–P68. https://doi.org/10.1359/jbmr.06s212
52.   Rubin, D. J., and Levin, R. M. Neurologic Complications of Paget Disease of Bone. Endocrine Practice. 2009; 15(2), 158–166. https://doi.org/10.4158/ep.15.2.158
53.   Wick, M. R., McLeod, R. A., Siegal, G. P., Greditzer, H. G., and Unni, K. K. Sarcomas of bone complicating osteitis deformans (Paget’s disease). The American Journal of Surgical Pathology. 1981; 5(1), 47–60. https://doi.org/10.1097/00000478-198101000-00008
54.   Greditzer, H. G., McLeod, R. A., Unni, K. K., and Beabout, J. W. Bone in Paget disease. Radiology.1983; 146(2),327–333.https://doi.org/10.1148/radiology.146.2.6571760
55.   IP; H. Malignant transformation in Paget disease of bone. Cancer. 2021; 70(12). https://doi.org/10.1002/1097-0142(19921215)70:12<2802::aid-cncr2820701213>3.0.co;2-n
56.   Altman, R. D., and Collins, B. Musculoskeletal manifestations of Paget’s disease of bone. Arthritis and Rheumatism. 1980; 23(10), 1121–1127. https://doi.org/10.1002/art.1780231008
57.   Wermers, R. A., Tiegs, R. D., Atkinson, E. J., Achenbach, S. J., and Melton, L. J. Morbidity and Mortality Associated with Paget’s Disease of Bone: A Population-Based Study. Journal of Bone and Mineral Research. 2008;23(6), 819–825. https://doi.org/10.1359/jbmr.080215